The majority of OI cases (type I-IV) are associated with reduced production of normal type I collagen or the synthesis of abnormal collagen as a result of pathogenic variants in COL1A1 and COL1A2 genes [3]. The gene discussed is COL1A2; the disease is osteogenesis imperfecta.